Pulse Logo
Visit Amazing Charts
Call us
800-444-0882
Request Demo
Talk to us.

To schedule a product demonstration, please enter the following, and we will be in touch shortly.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Certification, Costs
and Limitations

ALL VERSIONS
Costs and Limitations

Pulse Complete EHR may require one-time costs to establish interfaces for reporting to immunization registries, cancer registries, specialty registries, public health agencies and lab and radiology interfaces. Additional monthly interface support costs may be incurred upon client request.

Pulse Complete EHR is certified to data export criteria and can create a set of export summaries in real time. Though the user can create a set of export summaries in real time, this type of mass export is recommended as best practice to be scheduled during off-peak hours to reduce performance stress on the system.

Pulse Complete EHR may require annual fees associated with obtaining/maintaining certificates for communication through the HISP network.

Pulse Complete EHR may require monthly costs to support online patient services through the Pulse Patient Portal.

Pulse Complete EHR may require one-time costs to establish eprescribing functionality as well as monthly fees.

Additional Software

First DataBank, Medicomp Medcin Clinical Knowledge Engine.

Pulse Complete EHR 5.0.14
CHPL ID
150141R00
Certified
12/22/2015
This Pulse Complete EHR Version 5.0.14 is 2014 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.
Certification Criteria
  • 170.314(a)(1) – Computerized provider order entry
  • 170.314(a)(3) – Demographics
  • 170.314(a)(5) – Problem list
  • 170.314(a)(7) – Medication allergy list
  • 170.314(a)(9) – Electronic notes
  • 170.314(a)(11) – Smoking status
  • 170.314(a)(13) – Family health history
  • 170.314(a)(15) – Patient-specific education resources
  • 170.314(b)(2) – Transitions of care – create and transmit transition of care/referral summaries
  • 170.314(b)(4) – Clinical information reconciliation
  • 170.314(b)(7) – Data portability
  • 170.314(c)(2) – Clinical quality measures – import and calculate
  • 170.314(d)(1) – Authentication, access, control, and authorization
  • 170.314(d)(3) – Audit report(s)
  • 170.314(d)(5) – Automatic log-off
  • 170.314(d)(7) – End-user device encryption
  • 170.314(e)(1) – View, download, and transmit to a 3rd party with edge protocol testing
  • 170.314(e)(3) – Ambulatory setting only – secure messaging
  • 170.314(f)(2) – Transmission to immunization registries
  • 170.314(g)(2) – Automated measure calculation
  • 170.314(g)(4) – Quality management system
  • 170.314(a)(2) – Drug-drug, drug-allergy interactions checks
  • 170.314(a)(4) – Vital signs, body mass index, and growth Charts
  • 170.314(a)(6) – Medication list
  • 170.314(a)(8) – Clinical decision support
  • 170.314(a)(10) – Drug formulary checks
  • 170.314(a)(12) – Image results
  • 170.314(a)(14) – Patient list creation
  • 170.314(b)(1) – Transitions of care – receive, display and incorporate transition of care/referral summaries
  • 170.314(b)(3) – Electronic prescribing
  • 170.314(b)(5)(A) – Incorporate laboratory tests and values/results
  • 170.314(c)(1) – Clinical quality measures – capture and export
  • 170.314(c)(3) – Clinical quality measures – electronic submission
  • 170.314(d)(2) – Auditable events and tamper-resistance
  • 170.314(d)(4) – Amendments
  • 170.314(d)(6) – Emergency access
  • 170.314(d)(8) – Integrity
  • 170.314(e)(2) – Ambulatory setting only -clinical summary
  • 170.314(f)(1) – Immunization information
  • 170.314(f)(3) – Transmission to public health agencies – syndromic surveillance
  • 170.314(g)(3) – Safety-enhanced design
Clinical Quality Measures

CMS2: Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan

CMS22: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented

CMS50: Closing the Referral Loop: Receipt of Specialist Report

CMS52: HIV/AIDS: Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis

CMS56: Functional Status Assessment for Hip Replacement

CMS61: Preventive Care and Screening: Cholesterol – Fasting Low Density Lipoprotein (LDL-C) Test Performed

CMS62: HIV/AIDS: Medical Visit

CMS64: Preventive Care and Screening: Risk-Stratified Cholesterol -Fasting Low Density Lipoprotein (LDLC)

CMS65: Hypertension: Improvement in Blood Pressure

CMS66: Functional Status Assessment for Knee Replacement>

CMS68: Documentation of Current Medications in the Medical Record

CMS69: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan

CMS74: Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists

CMS75: Children Who Have Dental Decay or Cavities

CMS77: HIV/AIDS: RNA control for Patients with HIV

CMS82: Maternal Depression Screening

CMS90: Functional Status Assessment for Complex Chronic Conditions

CMS117: Childhood Immunization Status

CMS122: Diabetes: Hemoglobin A1c Poor Control

CMS123: Diabetes: Foot Exam

CMS124: Cervical Cancer Screening

CMS125: Breast Cancer Screening

CMS126: Use of Appropriate Medications for Asthma

CMS127: Pneumonia Vaccination Status for Older Adults

CMS128: Anti-depressant Medication Management

CMS129: Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients

CMS130: Colorectal Cancer Screening

CMS131: Diabetes: Eye Exam

CMS132: Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures

CMS133: Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery

CMS134: Diabetes: Urine Protein Screening

CMS135: Heart Failure (HF): AngiotensinConverting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)

CMS136: ADHD: Follow-Up Care for Children Prescribed AttentionDeficit/Hyperactivi ty Disorder (ADHD) Medication

CMS137: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment

CMS138: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

CMS139: Falls: Screening for Future Fall Risk

CMS140: Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/ Progesterone Receptor (ER/PR) Positive Breast Cancer

CMS141: Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients

CMS142: Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care

CMS143: Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation

CMS144: Heart Failure (HF): BetaBlocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

CMS145: Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%)

CMS146: Appropriate Testing for Children with Pharyngitis

CMS147: Preventive Care and Screening: Influenza Immunization

CMS148: Hemoglobin A1c Test for Pediatric Patients

CMS149: Dementia: Cognitive Assessment

CMS153: Chlamydia Screening for Women

CMS154: Appropriate Treatment for Children with Upper Respiratory Infection (URI)

CMS155: Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents

CMS156: Use of High-Risk Medications in the Elderly

CMS157: Oncology: Medical and Radiation – Pain Intensity Quantified

CMS158: Pregnant women that had HBsAg testing

CMS159: Depression Remission at Twelve Months

CMS160: Depression Utilization of the PHQ-9 Tool

CMS161: Adult Major Depressive Disorder (MDD): Suicide Risk Assessment

CMS163: Diabetes: Low Density Lipoprotein (LDL) Management

CMS164: Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic

CMS165: Controlling High Blood Pressure

CMS166: Use of Imaging Studies for Low Back Pain

CMS167: Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy

CMS169: Bipolar Disorder and Major Depression: Appraisal for alcohol or chemical substance use

CMS177: Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment

CMS179: ADE Prevention and Monitoring: Warfarin Time in Therapeutic Range

CMS182: Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control>

Pulse Complete EHR 5.0.01
CHPL ID
140276R01
Certified
5/13/2015
This Pulse Complete EHR Version 5.0.01 is 2014 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.
Certification Criteria
  • 170.314(a)(1) – Computerized provider order entry
  • 170.314(a)(3) – Demographics
  • 170.314(a)(5) – Problem list
  • 170.314(a)(7) – Medication allergy list
  • 170.314(a)(9) – Electronic notes
  • 170.314(a)(11) – Smoking status
  • 170.314(a)(13) – Family health history
  • 170.314(a)(15) – Patient-specific education resources
  • 170.314(b)(2) – Transitions of care – create and transmit transition of care/referral summaries
  • 170.314(b)(4) – Clinical information reconciliation
  • 170.314(b)(7) – Data portability
  • 170.314(c)(2) – Clinical quality measures – import and calculate
  • 170.314(d)(1) – Authentication, access, control, and authorization
  • 170.314(d)(3) – Audit report(s)
  • 170.314(d)(5) – Automatic log-off
  • 170.314(d)(7) – End-user device encryption
  • 170.314(d)(9) – Optional – accounting of disclosures
  • 170.314(e)(1) – View, download, and transmit to a 3rd party with edge protocol testing
  • 170.314(e)(3) – Ambulatory setting only – secure messaging
  • 170.314(f)(2) – Transmission to immunization registries
  • 170.314(g)(2) – Automated measure calculation
  • 170.314(g)(4) – Quality management system
  • 170.314(a)(2) – Drug-drug, drug-allergy interactions checks
  • 170.314(a)(4) – Vital signs, body mass index, and growth Charts
  • 170.314(a)(6) – Medication list
  • 170.314(a)(8) – Clinical decision support
  • 170.314(a)(10) – Drug formulary checks
  • 170.314(a)(12) – Image results
  • 170.314(a)(14) – Patient list creation
  • 170.314(b)(1) – Transitions of care – receive, display and incorporate transition of care/referral summaries
  • 170.314(b)(3) – Electronic prescribing
  • 170.314(b)(5)(A) – Incorporate laboratory tests and values/results
  • 170.314(c)(1) – Clinical quality measures – capture and export
  • 170.314(c)(3) – Clinical quality measures – electronic submission
  • 170.314(d)(2) – Auditable events and tamper-resistance
  • 170.314(d)(4) – Amendments
  • 170.314(d)(6) – Emergency access
  • 170.314(d)(8) – Integrity
  • 170.314(e)(2) – Ambulatory setting only -clinical summary
  • 170.314(f)(1) – Immunization information
  • 170.314(f)(3) – Transmission to public health agencies – syndromic surveillance
  • 170.314(g)(3) – Safety-enhanced design

‍

Clinical Quality Measures

CMS2: Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan

CMS22: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented

CMS50: Closing the Referral Loop: Receipt of Specialist Report

CMS52: HIV/AIDS: Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis

CMS56: Functional Status Assessment for Hip Replacement

CMS61: Preventive Care and Screening: Cholesterol – Fasting Low Density Lipoprotein (LDL-C) Test Performed

CMS62: HIV/AIDS: Medical Visit

CMS64: Preventive Care and Screening: Risk-Stratified Cholesterol -Fasting Low Density Lipoprotein (LDLC)

CMS65: Hypertension: Improvement in Blood Pressure

CMS66: Functional Status Assessment for Knee Replacement>

CMS68: Documentation of Current Medications in the Medical Record

CMS69: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan

CMS74: Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists

CMS75: Children Who Have Dental Decay or Cavities

CMS77: HIV/AIDS: RNA control for Patients with HIV

CMS82: Maternal Depression Screening

CMS90: Functional Status Assessment for Complex Chronic Conditions

CMS117: Childhood Immunization Status

CMS122: Diabetes: Hemoglobin A1c Poor Control

CMS123: Diabetes: Foot Exam

CMS124: Cervical Cancer Screening

CMS125: Breast Cancer Screening

CMS126: Use of Appropriate Medications for Asthma

CMS127: Pneumonia Vaccination Status for Older Adults

CMS128: Anti-depressant Medication Management

CMS129: Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients

CMS130: Colorectal Cancer Screening

CMS131: Diabetes: Eye Exam

CMS132: Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures

CMS133: Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery

CMS134: Diabetes: Urine Protein Screening

CMS135: Heart Failure (HF): AngiotensinConverting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)

CMS136: ADHD: Follow-Up Care for Children Prescribed AttentionDeficit/Hyperactivi ty Disorder (ADHD) Medication

CMS137: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment

CMS138: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

CMS139: Falls: Screening for Future Fall Risk

CMS140: Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/ Progesterone Receptor (ER/PR) Positive Breast Cancer

CMS141: Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients

CMS142: Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care

CMS143: Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation

CMS144: Heart Failure (HF): BetaBlocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

CMS145: Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%)

CMS146: Appropriate Testing for Children with Pharyngitis

CMS147: Preventive Care and Screening: Influenza Immunization

CMS148: Hemoglobin A1c Test for Pediatric Patients

CMS149: Dementia: Cognitive Assessment

CMS153: Chlamydia Screening for Women

CMS154: Appropriate Treatment for Children with Upper Respiratory Infection (URI)

CMS155: Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents

CMS156: Use of High-Risk Medications in the Elderly

CMS157: Oncology: Medical and Radiation – Pain Intensity Quantified

CMS158: Pregnant women that had HBsAg testing

CMS159: Depression Remission at Twelve Months

CMS160: Depression Utilization of the PHQ-9 Tool

CMS161: Adult Major Depressive Disorder (MDD): Suicide Risk Assessment

CMS163: Diabetes: Low Density Lipoprotein (LDL) Management

CMS164: Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic

CMS165: Controlling High Blood Pressure

CMS166: Use of Imaging Studies for Low Back Pain

CMS167: Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy

CMS169: Bipolar Disorder and Major Depression: Appraisal for alcohol or chemical substance use

CMS177: Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment

CMS179: ADE Prevention and Monitoring: Warfarin Time in Therapeutic Range

CMS182: Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control

‍

Pulse Complete EHR 5.0
CHPL ID
140276R00
Certified
10/2/2014
This Pulse Complete EHR Version 5.0 is 2014 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.
Certification Criteria
  • 170.314(a)(1) – Computerized provider order entry
  • 170.314(a)(3) – Demographics
  • 170.314(a)(5) – Problem list
  • 170.314(a)(7) – Medication allergy list
  • 170.314(a)(9) – Electronic notes
  • 170.314(a)(11) – Smoking status
  • 170.314(a)(13) – Family health history
  • 170.314(a)(15) – Patient-specific education resources
  • 170.314(b)(2) – Transitions of care – create and transmit transition of care/referral summaries
  • 170.314(b)(4) – Clinical information reconciliation
  • 170.314(b)(7) – Data portability
  • 170.314(c)(2) – Clinical quality measures – import and calculate
  • 170.314(d)(1) – Authentication, access, control, and authorization
  • 170.314(d)(3) – Audit report(s)
  • 170.314(d)(5) – Automatic log-off
  • 170.314(d)(7) – End-user device encryption
  • 170.314(d)(9) – Optional – accounting of disclosures
  • 170.314(e)(2) – Ambulatory setting only – clinical summary
  • 170.314(f)(1) – Immunization information
  • 170.314(f)(3) – Transmission to public health agencies – syndromic surveillance
  • 170.314(g)(3) – Safety-enhanced design
  • 170.314(a)(2) – Drug-drug, drug-allergy interactions checks
  • 170.314(a)(4) – Vital signs, body mass index, and growth Charts
  • 170.314(a)(6) – Medication list
  • 170.314(a)(8) – Clinical decision support
  • 170.314(a)(10) – Drug formulary checks
  • 170.314(a)(12) – Image results
  • 170.314(a)(14) – Patient list creation
  • 170.314(b)(1) – Transitions of care – receive, display and incorporate transition of care/referral summaries
  • 170.314(b)(3) – Electronic prescribing
  • 170.314(b)(5)(A) – Incorporate laboratory tests and values/results
  • 170.314(c)(1) – Clinical quality measures – capture and export
  • 170.314(c)(3) – Clinical quality measures – electronic submission
  • 170.314(d)(2) – Auditable events and tamper-resistance
  • 170.314(d)(4) – Amendments
  • 170.314(d)(6) – Emergency access
  • 170.314(d)(8) – Integrity
  • 170.314(e)(1) – View, download, and transmit to a 3rd party with edge protocol testing
  • 170.314(e)(3) – Ambulatory setting only – secure messaging
  • 170.314(f)(2) – Transmission to immunization registries
  • 170.314(g)(2) – Automated measure calculation
  • 170.314(g)(4) – Quality management system

‍

Clinical Quality Measures

CMS2: Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan

CMS22: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented

CMS50: Closing the Referral Loop: Receipt of Specialist Report

CMS52: HIV/AIDS: Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis

CMS56: Functional Status Assessment for Hip Replacement

CMS61: Preventive Care and Screening: Cholesterol – Fasting Low Density Lipoprotein (LDL-C) Test Performed

CMS62: HIV/AIDS: Medical Visit

CMS64: Preventive Care and Screening: Risk-Stratified Cholesterol -Fasting Low Density Lipoprotein (LDLC)

CMS65: Hypertension: Improvement in Blood Pressure

CMS66: Functional Status Assessment for Knee Replacement>

CMS68: Documentation of Current Medications in the Medical Record

CMS69: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan

CMS74: Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists

CMS75: Children Who Have Dental Decay or Cavities

CMS77: HIV/AIDS: RNA control for Patients with HIV

CMS82: Maternal Depression Screening

CMS90: Functional Status Assessment for Complex Chronic Conditions

CMS117: Childhood Immunization Status

CMS122: Diabetes: Hemoglobin A1c Poor Control

CMS123: Diabetes: Foot Exam

CMS124: Cervical Cancer Screening

CMS125: Breast Cancer Screening

CMS126: Use of Appropriate Medications for Asthma

CMS127: Pneumonia Vaccination Status for Older Adults

CMS128: Anti-depressant Medication Management

CMS129: Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients

CMS130: Colorectal Cancer Screening

CMS131: Diabetes: Eye Exam

CMS132: Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures

CMS133: Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery

CMS134: Diabetes: Urine Protein Screening

CMS135: Heart Failure (HF): AngiotensinConverting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)

CMS136: ADHD: Follow-Up Care for Children Prescribed AttentionDeficit/Hyperactivi ty Disorder (ADHD) Medication

CMS137: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment

CMS138: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

CMS139: Falls: Screening for Future Fall Risk

CMS140: Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/ Progesterone Receptor (ER/PR) Positive Breast Cancer

CMS141: Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients

CMS142: Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care

CMS143: Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation

CMS144: Heart Failure (HF): BetaBlocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

CMS145: Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%)

CMS146: Appropriate Testing for Children with Pharyngitis

CMS147: Preventive Care and Screening: Influenza Immunization

CMS148: Hemoglobin A1c Test for Pediatric Patients

CMS149: Dementia: Cognitive Assessment

CMS153: Chlamydia Screening for Women

CMS154: Appropriate Treatment for Children with Upper Respiratory Infection (URI)

CMS155: Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents

CMS156: Use of High-Risk Medications in the Elderly

CMS157: Oncology: Medical and Radiation – Pain Intensity Quantified

CMS158: Pregnant women that had HBsAg testing

CMS159: Depression Remission at Twelve Months

CMS160: Depression Utilization of the PHQ-9 Tool

CMS161: Adult Major Depressive Disorder (MDD): Suicide Risk Assessment

CMS163: Diabetes: Low Density Lipoprotein (LDL) Management

CMS164: Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic

CMS165: Controlling High Blood Pressure

CMS166: Use of Imaging Studies for Low Back Pain

CMS167: Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy

CMS169: Bipolar Disorder and Major Depression: Appraisal for alcohol or chemical substance use

CMS177: Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment

CMS179: ADE Prevention and Monitoring: Warfarin Time in Therapeutic Range

CMS182: Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control>

‍